major-depressive-disorder

Documents about major-depressive-disorder

• Synaptic Imaging and Network Activity in Treatment Resistant Depression#835038ClinicalTrials.gov
• The Antidiabetic Metformin as a Novel Adjunct to Antidepressants in Major Depressive Disorder Patients#432869ClinicalTrials.gov
• Brain GABA Levels and Treatment Response in Major Depressive Disorder#830825ClinicalTrials.gov
• The Effects of Dopamine on Reward Processing#860378ClinicalTrials.gov
• Sustained Ketamine Effectiveness for Suicidal Ideation#866553ClinicalTrials.gov
• Exergames-acceptance and Commitment Therapy Program for Treatment of Major Depressive Disorder#866607ClinicalTrials.gov
• Safety and Efficacy of Levomilnacipran ER in Adolescent Participants With Major Depressive Disorder#871882ClinicalTrials.gov
• A Study of Brexpiprazole in Patients With Major Depressive Disorder#877300ClinicalTrials.gov
• Characterization of Microbial, Immune and Epigenetic Biomarkers for Major Depressive Disorder and ECT Treatment#885334ClinicalTrials.gov
• Understanding Brain Reward Responses in Individuals With Major Depressive Disorder#890115ClinicalTrials.gov
• A Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder (MDD)#1009296ClinicalTrials.gov
• Study Evaluating DVS-233 SR in Adult Outpatients With Major Depressive Disorder#860122ClinicalTrials.gov
• A Long-Term Study of Brexpiprazole in Patients With Major Depressive Disorder#802760ClinicalTrials.gov
• A Phase 3 Study of Lu AA21004 in Patients With Major Depressive Disorder#810998ClinicalTrials.gov
• NMDA Modulation in Antidepressant Nonresponders With Major Depressive Disorder#872089ClinicalTrials.gov
• Non-invasive Brain Stimulation in Subjects with Major Depressive Disorder#881170ClinicalTrials.gov
• Duloxetine Versus Placebo in the Prevention of Recurrence of Major Depressive Disorder#885926ClinicalTrials.gov
• A Study of Fluoxetine in Major Depressive Disorder (MDD) Short-Term Dosing#893899ClinicalTrials.gov
• The DPP-4 Inhibitor Vildagliptin as Adjunct in Major Depressive Disorder Patients#916167ClinicalTrials.gov
• Practical Application of Accelerated iTBS for MDD#803833ClinicalTrials.gov
• Psychiatric Genotype/Phenotype Project Repository#859472ClinicalTrials.gov
• Study Evaluating Desvenlafaxine Succinate Sustained-Release (DVS SR) in Adult Outpatients With Major Depressive Disorder (MDD)#810441ClinicalTrials.gov
• Efficacy of Seroquel SR in Combination With an Antidepressant in Treatment of Major Depressive Disorder#829505ClinicalTrials.gov
• A Study in the Treatment of Children and Adolescents With Major Depressive Disorder#844219ClinicalTrials.gov
• Efficacy and Safety of Intradermal Acupuncture for Major Depressive Disorder#870985ClinicalTrials.gov
• Trial of a Positive Psychology Intervention in Major Depressive Disorder#875490ClinicalTrials.gov
• Efficacy Study of RX-10100 to Treat Major Depressive Disorder (MDD)#883468ClinicalTrials.gov
• Efficacy and Safety of DOV 21,947 in the Treatment of Major Depressive Disorder#889943ClinicalTrials.gov
• Pentoxifylline as an Adjunct to Citalopram in Adult Patients With Major Depressive Disorder#908251ClinicalTrials.gov
• A Study of Duloxetine in Major Depressive Disorder (MDD) and Associated Painful Symptoms#909460ClinicalTrials.gov
• Study of Aripiprazole as an Adjunctive Therapy in Patients With Major Depressive Disorder#969799ClinicalTrials.gov
• Study to Assess the Effects of Intranasal Ketamine Along With rTMS for Patients With Treatment-resistant Major Depressive Disorder (TRD)#833337ClinicalTrials.gov
• Nitrous Oxide for the Treatment of Major Depressive Disorder#903224ClinicalTrials.gov
• Functional Magnetic Resonance Imaging Study of Inhibitory Control in Bipolar Disorder and Major Depressive Disorder#898501ClinicalTrials.gov
• Antidepressant Decision Aid for Major Depressive Disorder Patients#875641ClinicalTrials.gov
• An Open-Label Extension Study to Evaluate the Safety and Tolerability of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 OLE Study)#967321ClinicalTrials.gov
• A 12-Week, Placebo Controlled Trial of Ziprasidone as Monotherapy for Major Depressive Disorder#825049ClinicalTrials.gov
• Chart Review of Patients Undergoing Ketamine Treatments for Depression#800167ClinicalTrials.gov
• Using Voice Biomarkers to Predict the Likelihood of Major Depressive Disorder#828175ClinicalTrials.gov
• An Efficacy and Safety Study of Sirukumab in Participants With Major Depressive Disorder#836121ClinicalTrials.gov
• Acceptance and Commitment Therapy Versus Cognitive Therapy for the Treatment of Major Depressive Disorder#850646ClinicalTrials.gov
• A Study of GW856553X For the Treatment of Depression#872707ClinicalTrials.gov
• Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder#896106ClinicalTrials.gov
• Alpha-Stim AID and Major Depressive Disorder#914451ClinicalTrials.gov
• Dose-Ranging Trial of Creatine Augmentation for Adolescent Females With Treatment-Resistant Major Depressive Disorder#966346ClinicalTrials.gov
• Effect of Probiotic Supplement on Improvement of Depressive Symptoms in Patients With Substance-Induced Depressive Disorder#890664ClinicalTrials.gov
• Behavioural Activation Therapy and Esketamine for Resistant Depression#838845ClinicalTrials.gov
• Stingless Bee Honey Augmentation in Major Depressive Disorders#874155ClinicalTrials.gov
• Pioglitazone for the Treatment of Major Depressive Disorder Comorbid With Metabolic Syndrome#807261ClinicalTrials.gov
• The Study of Mindfulness-based Cognitive Therapy and Major Depressive Disorder#827914ClinicalTrials.gov